Skip to main content
. 2018 May 15;32(3):245–253. doi: 10.1007/s10557-018-6793-y

Fig. 5.

Fig. 5

a 2 μM doxorubicin (Dox) increased cell death in HeLa cancer cells significantly, but preconditioning did not protect them (n = 5). b Akt was not phosphorylated in response to sIPC in HeLa cells